Compare FMS & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FMS | UHS |
|---|---|---|
| Founded | 1996 | 1978 |
| Country | Germany | United States |
| Employees | 108165 | N/A |
| Industry | Misc Health and Biotechnology Services | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 9.3B |
| IPO Year | N/A | 1994 |
| Metric | FMS | UHS |
|---|---|---|
| Price | $23.01 | $147.34 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $30.00 | ★ $216.36 |
| AVG Volume (30 Days) | 641.6K | ★ 948.8K |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | ★ 2.57% | 0.48% |
| EPS Growth | N/A | ★ 37.34 |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $17,364,829,000.00 |
| Revenue This Year | N/A | $7.67 |
| Revenue Next Year | $3.83 | $4.99 |
| P/E Ratio | ★ $15.62 | $25.92 |
| Revenue Growth | N/A | ★ 9.71 |
| 52 Week Low | $20.02 | $140.08 |
| 52 Week High | $28.87 | $246.33 |
| Indicator | FMS | UHS |
|---|---|---|
| Relative Strength Index (RSI) | 60.95 | 39.24 |
| Support Level | $22.50 | N/A |
| Resistance Level | $24.02 | $191.29 |
| Average True Range (ATR) | 0.31 | 4.74 |
| MACD | 0.18 | 0.55 |
| Stochastic Oscillator | 97.80 | 37.42 |
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.